Bern, Switzerland and Tucson, AZ - 28 May 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and positron-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its prototype iQID Scope window-chamber particle imager at Universitätsspital Bern. The iQID Scope is aimed to meet the emerging need for real-time, intravital microscopy of radiopharmaceuticals.
QScint President Dr. Brian Miller noted: “We’re thrilled to develop and deliver this cutting-edge tool to Dr. Shi and his team of researchers for live-imaging of alpha-emitters in living tissue at microscale levels and in the context of the ongoing biological processes. We believe window-chamber imaging in combination with our patented real-time imaging technology will fundamentally change the understanding of intravital tumor growth and response to targeted alpha therapy. We’re pleased to see Dr. Shi and Universitätsspital Bern get this tool. This will be the first-ever demonstration of live tumor-imaging of alpha emitters at a near-cellular level.”
